Challenges, opportunities, and innovative statistical designs for precision oncology trials

In the era of precision oncology, improved understanding of tumor heterogeneity, particularly at the molecular level, has caused a shift from traditionally histology based cancer drug development to molecularly targeted drug development. The shift to the molecular view of cancer leads to increasingl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jun, Shen, Shihao, Shi, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article on Challenges in Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577796/
https://www.ncbi.nlm.nih.gov/pubmed/36267789
http://dx.doi.org/10.21037/atm-22-356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577796/
https://www.ncbi.nlm.nih.gov/pubmed/36267789
http://dx.doi.org/10.21037/atm-22-356

Ejemplares similares